Cardiac and renal biomarker responses in a phase 1/2 study of NEOD001 in patients with AL amyloidosis and persistent organ dysfunction. Gertz, M. A., Landau, H., Comenzo, R., Seldin, D. C., Weiss, B. M., Zonder, J. A., Walling, J., Kinney, G., Koller, M., Liedtke, M. AMER SOC CLINICAL ONCOLOGY. 2015

View details for Web of Science ID 000358036901826